Cargando…
Update on the safety and efficacy of teriparatide in the treatment of osteoporosis
Following the completion of the Fracture Prevention Trial, teriparatide was approved by the United States Food and Drug Administration and the European Medicine Agency as the first therapeutic anabolic agent for the treatment of postmenopausal women with severe osteoporosis. It subsequently received...
Autores principales: | Minisola, Salvatore, Cipriani, Cristiana, Grotta, Giada Della, Colangelo, Luciano, Occhiuto, Marco, Biondi, Piergianni, Sonato, Chiara, Vigna, Evelina, Cilli, Mirella, Pepe, Jessica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6778993/ https://www.ncbi.nlm.nih.gov/pubmed/31632472 http://dx.doi.org/10.1177/1759720X19877994 |
Ejemplares similares
-
Occipital bone and tumor-induced osteomalacia: a rare tumor site for an uncommon paraneoplastic syndrome
por: Colangelo, Luciano, et al.
Publicado: (2023) -
Vitamin D and Its Relationship with Obesity and Muscle
por: Cipriani, Cristiana, et al.
Publicado: (2014) -
COVID pandemic and denosumab adherence
por: Minisola, S., et al.
Publicado: (2022) -
Lumbar spine bone mineral density and trabecular bone score-adjusted FRAX, but not FRAX without bone mineral density, identify subclinical carotid atherosclerosis
por: Pepe, J., et al.
Publicado: (2021) -
Genetic aspects underlying the normocalcemic and hypercalcemic phenotypes of primary hyperparathyroidism
por: Viviani, Arianna, et al.
Publicado: (2023)